Senores Pharmaceuticals expands US footprint with Roflumilast ANDA acquisition
Senores Pharmaceuticals Limited has taken a significant step in its US expansion strategy by acquiring an Abbreviated New Drug Application (ANDA) for Roflumilast 250 mcg ... Read More
EMA approves Dupixent as first biologic for COPD with elevated eosinophils
The European Medicines Agency (EMA) has granted approval to Dupixent (dupilumab) as a novel add-on maintenance treatment for adults with uncontrolled chronic obstructive pulmonary disease ... Read More
Understanding Chronic Obstructive Pulmonary Disease (COPD): A comprehensive guide
Chronic Obstructive Pulmonary Disease, or COPD, is a progressive lung condition that encompasses emphysema and chronic bronchitis, often leading to severe respiratory issues. Affecting approximately ... Read More